Children aged 6 months old can get the Pfizer-BioNTech COVID-19 vaccination. The vaccine has been given full FDA approval for use in those aged 12 and older and emergency use authorization (EUA) for those aged 6 months to 11 years. Parents of school-aged children have started to speculate about whether or not vaccinations would be made mandatory in public schools.
The point at which individual institutions can impose regulations varies. Some have proposed regulations already, while others may choose to wait.
All of the routine immunizations recommended by the American Academy of Pediatrics are mandated for students attending public schools in the United States (AAP). Parents who do not wish for their children to follow these rules can usually apply for an exemption. Some parents wonder if this is also true for the COVID-19 vaccine.
Vaccines are a terrific method to keep kids healthy and in school, and they’re also safe and effective. However, mandates do work, despite widespread opposition, therefore it may be preferable to encourage and try to convince individuals to be vaccinated willingly.
Schools may consider a number of factors when considering whether or not to impose the COVID-19 vaccine for kids.
Complete Clearance By The Food And Drug Administration.
After years of testing, the Pfizer-BioNTech vaccine has received final approval from the FDA for use in children and adolescents over the age of 12. However, Pfizer and Moderna are distributing their vaccines to children under the age of 12 and 18 under an emergency use authorization [EUA], which is a considerably quicker process than the FDA’s full approval process for a vaccine.
On January 31, 2022, the FDA approved the Moderna vaccine for use in adults.
Acquiring final FDA approval is a time-consuming procedure that requires reviewing a variety of information provided by the vaccine manufacturer, such as:
- Specifics on how the product is made.
- The vaccine production facilities were checked out.
- Observations from both preclinical and clinical settings.
- Evaluations of several vaccines.
Full approval for ages 12 and up for the Pfizer vaccine occurred less than a year after its EUA, which is significantly faster than the norm. Timelines for complete FDA clearance of a children’s vaccination have not been established.
Both those applying and those reviewing must put in a lot of effort.
Schools may have trouble demanding a vaccine that hasn’t gained official FDA approval like other needed immunizations, but this doesn’t indicate the vaccine is harmful by any means.
Both Pfizer’s vaccination for infants and children aged 6 months to 11 years and Moderna’s vaccine for those younger than 18 are now being used with emergency use authorization (EUA). Some school districts may wait for full FDA approval before debating COVID-19 vaccine obligations, which is a more time-consuming process.
Consequences of COVID’s Potential Spread among Children.
Researchers have confirmed that the virus may be passed just as easily from child to child as it does between adults. This means they can spread COVID-19 under a wide variety of conditions, such as:
- No signs of illness.
- When just modest symptoms are present.
- When the patient is experiencing vague or generalized discomfort.
- If they aren’t aware of their infection
Communities with higher COVID-19 infection rates are more likely to see the virus spread in local educational institutions. The CDC advocates for multilayered approaches to prevention.
Wearing masks, being vaccinated, keeping a safe distance, testing, and screening all help lower the spread of COVID-19 in schools. However, not every institution follows these norms.
The Potential Dangers of the Virus in Relation to the Vaccine.
Last but not least, the fact that most children experience only mild symptoms from COVID-19 is a major consideration for schools debating whether or not to require vaccination.
Nearly 13.8 million American children have contracted COVID-19 as of July 5, 2022. The final week of January 2022 accounted for about a million of these occurrences. Since the pandemic began, 18.7 percent of victims have been children.
Hospitalizations ranged from 1.6% to 4.4% of all cases in the states that provided data, with children making up anywhere in the middle.
Another 829 children under the age of 18 and 431 children aged 5 or younger have lost their lives to COVID-19 as of July 6, 2022. Vaccination is the best strategy to protect children’s health and prevent what is usually a mild disease from becoming much more serious or even fatal in children.
This condition, like the rest of the COVID-19 pandemic, is fluid and changing. Vaccination against COVID-19 is now available for infants as early as 6 months old.
After final FDA approval for usage in all age groups, politicians, scientists, and health professionals will decide whether the COVID-19 vaccine should be added to the necessary vaccines for school attendance.